Financials Merck KGaA

Equities

MRK

DE0006599905

Pharmaceuticals

Real-time Estimate Tradegate 09:00:43 2024-05-28 am EDT 5-day change 1st Jan Change
167.4 EUR +0.03% Intraday chart for Merck KGaA +0.88% +16.00%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 45,804 61,021 98,695 78,651 62,651 72,782 - -
Enterprise Value (EV) 1 58,160 71,683 107,596 86,979 62,651 79,058 77,227 75,051
P/E ratio 34.7 x 30.7 x 32.3 x 23.6 x 22.2 x 24.1 x 20.4 x 18.3 x
Yield 1.23% 1% 0.81% 1.22% - 1.33% 1.45% 1.52%
Capitalization / Revenue 2.84 x 3.48 x 5.01 x 3.54 x 2.98 x 3.42 x 3.23 x 3.06 x
EV / Revenue 3.6 x 4.09 x 5.47 x 3.91 x 2.98 x 3.72 x 3.42 x 3.15 x
EV / EBITDA 13.3 x 13.8 x 17.6 x 12.7 x 10.7 x 13.4 x 11.7 x 10.5 x
EV / FCF 28.5 x 34.7 x 30.3 x 31.9 x - 27 x 25.2 x 21.6 x
FCF Yield 3.51% 2.88% 3.3% 3.14% - 3.7% 3.96% 4.63%
Price to Book 2.56 x 3.59 x 4.63 x 3.03 x - 2.51 x 2.31 x 2.12 x
Nbr of stocks (in thousands) 434,778 434,778 434,778 434,778 434,778 434,778 - -
Reference price 2 105.4 140.4 227.0 180.9 144.1 167.4 167.4 167.4
Announcement Date 3/5/20 3/4/21 3/3/22 3/2/23 3/7/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 16,152 17,534 19,687 22,232 20,993 21,280 22,561 23,810
EBITDA 1 4,385 5,201 6,103 6,849 5,879 5,916 6,575 7,142
EBIT 1 2,120 2,985 4,179 4,474 3,609 4,062 4,641 5,170
Operating Margin 13.13% 17.02% 21.23% 20.12% 17.19% 19.09% 20.57% 21.72%
Earnings before Tax (EBT) 1 1,735 2,630 3,924 4,287 3,484 3,830 4,440 4,971
Net income 1 1,320 1,987 3,055 3,326 2,824 3,001 3,550 3,953
Net margin 8.17% 11.33% 15.52% 14.96% 13.45% 14.1% 15.74% 16.6%
EPS 2 3.040 4.570 7.030 7.650 6.490 6.956 8.222 9.158
Free Cash Flow 1 2,043 2,065 3,550 2,728 - 2,926 3,061 3,474
FCF margin 12.65% 11.78% 18.03% 12.27% - 13.75% 13.57% 14.59%
FCF Conversion (EBITDA) 46.6% 39.7% 58.17% 39.83% - 49.45% 46.56% 48.64%
FCF Conversion (Net income) 154.77% 103.9% 116.22% 82.02% - 97.5% 86.23% 87.89%
Dividend per Share 2 1.300 1.400 1.850 2.200 - 2.233 2.420 2.546
Announcement Date 3/5/20 3/4/21 3/3/22 3/2/23 3/7/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 8,489 5,213 5,198 5,568 5,806 5,660 5,293 5,302 5,173 5,225 5,120 5,250 5,389 5,529 - -
EBITDA 1 2,256 1,464 1,629 1,782 1,810 1,628 1,587 1,553 1,446 1,293 1,454 1,419 1,489 1,608 - -
EBIT 1 - 1,039 1,173 1,177 1,234 889.6 1,035 969 983 621 931 832.5 1,078 1,086 - -
Operating Margin - 19.93% 22.57% 21.14% 21.26% 15.72% 19.55% 18.28% 19% 11.89% 18.18% 15.86% 20.01% 19.65% - -
Earnings before Tax (EBT) 1 - 991.9 1,139 1,122 1,187 839.1 1,012 894 937 641 899 807.4 1,053 1,063 - -
Net income 1 - 802.1 880.4 867.1 923.2 655 796 704 739 586 694 741.5 809.9 881.4 - -
Net margin - 15.39% 16.94% 15.57% 15.9% 11.57% 15.04% 13.28% 14.29% 11.22% 13.55% 14.13% 15.03% 15.94% - -
EPS 2 1.720 1.840 2.020 1.990 2.120 1.510 1.830 1.620 1.700 1.340 1.600 1.603 1.862 2.018 - -
Dividend per Share 2 - 1.850 - - - 2.200 - - - - - 0.5500 0.5500 0.5500 0.6000 0.6000
Announcement Date 8/6/20 3/3/22 5/12/22 8/4/22 11/10/22 3/2/23 5/11/23 8/3/23 11/9/23 3/7/24 5/15/24 - - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 12,357 10,662 8,902 8,328 - 6,277 4,446 2,269
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.818 x 2.05 x 1.459 x 1.216 x - 1.061 x 0.6762 x 0.3177 x
Free Cash Flow 1 2,043 2,065 3,550 2,728 - 2,926 3,061 3,474
ROE (net income / shareholders' equity) 13.8% 16.7% 19.8% 18.5% - 13.6% 14.3% 14.6%
ROA (Net income/ Total Assets) 3.27% 4.64% 8.7% 9.31% - 6.5% 7.43% 7.8%
Assets 1 40,348 42,804 35,111 35,718 - 46,156 47,786 50,677
Book Value Per Share 2 41.10 39.10 49.10 59.60 - 66.60 72.50 78.80
Cash Flow per Share 2 6.580 8.000 10.60 9.800 - 10.90 11.50 12.60
Capex 1 813 1,413 1,066 1,531 - 1,695 1,965 1,988
Capex / Sales 5.03% 8.06% 5.41% 6.89% - 7.96% 8.71% 8.35%
Announcement Date 3/5/20 3/4/21 3/3/22 3/2/23 3/7/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
167.4 EUR
Average target price
183.6 EUR
Spread / Average Target
+9.66%
Consensus
  1. Stock Market
  2. Equities
  3. MRK Stock
  4. Financials Merck KGaA